Search research articles
Contact Us
Filters
Showing results (1-10 of 130) with videos related to
Page
of 13
Sort By:
Seminars in Oncology
|
March 14, 2003
Molecular and cellular biology of small cell lung cancer
Martin Sattler, Ravi Salgia
Leukemia Research
|
March 24, 2004
Targeting c-Kit mutations: basic science to novel therapies
Martin Sattler, Ravi Salgia
Current Oncology Reports
|
February 10, 2007
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy
Martin Sattler, Ravi Salgia
Science Translational Medicine
|
October 25, 2013
A new hope for precision medicine
Ravi Salgia, Martin Sattler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2022
Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor
Martin Sattler, Ravi Salgia
Translational Lung Cancer Research
|
July 10, 2023
LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer
Martin Sattler, Ravi Salgia
Critical Reviews in Oncology/Hematology
|
October 11, 2005
Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
Christoph Walz, Martin Sattler
Cancers
|
May 11, 2024
The Role of Surgery in Pleural Mesothelioma
Moshe Lapidot, Martin Sattler
Expert Opinion on Therapeutic Targets
|
May 27, 2004
Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias
Lolita Banerji, Martin Sattler
Update on Cancer Therapeutics
|
April 7, 2010
The MET axis as a therapeutic target
Martin Sattler, Ravi Salgia
Page
of 13
Search research articles
Search
Showing results (1-10 of 130) with videos related to
Sort By:
Page
of 13
Seminars in Oncology
|
March 14, 2003
Molecular and cellular biology of small cell lung cancer
Martin Sattler, Ravi Salgia
Leukemia Research
|
March 24, 2004
Targeting c-Kit mutations: basic science to novel therapies
Martin Sattler, Ravi Salgia
Current Oncology Reports
|
February 10, 2007
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy
Martin Sattler, Ravi Salgia
Science Translational Medicine
|
October 25, 2013
A new hope for precision medicine
Ravi Salgia, Martin Sattler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2022
Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor
Martin Sattler, Ravi Salgia
Translational Lung Cancer Research
|
July 10, 2023
LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer
Martin Sattler, Ravi Salgia
Critical Reviews in Oncology/Hematology
|
October 11, 2005
Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
Christoph Walz, Martin Sattler
Cancers
|
May 11, 2024
The Role of Surgery in Pleural Mesothelioma
Moshe Lapidot, Martin Sattler
Expert Opinion on Therapeutic Targets
|
May 27, 2004
Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias
Lolita Banerji, Martin Sattler
Update on Cancer Therapeutics
|
April 7, 2010
The MET axis as a therapeutic target
Martin Sattler, Ravi Salgia
Page
of 13